Skip to content

Investigating the effect of bioresonance on chronic urticaria

evaluation of the effect of Bioresonance Therapy (BRT) as a temperament modulator on patients with chronic Urticaria: a multicenter randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200323046841N2
Enrollment
80
Registered
2022-12-04
Start date
2023-01-21
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urticaria. Urticaria

Interventions

Intervention 1: Intervention group: The intervention group will receive water magnified by the Imedis MiniExpert DT bioresonance device for one month, three times a day and half a cc each time, sublin

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with clinically chronic urticaria according to the 2018 EAACI/GA2LEN/EDF/WAO guidelines

Exclusion criteria

Exclusion criteria: Immunodeficient patients Users of corticosteroids or drug-affected immune system Abnormal thyroid tests Drug abuse Pregnancy and breastfeeding Simultaneous use of herbal drugs or traditional medical treatments such as cupping or phlebotomy or leech therapy or local drugs No tendency to cooperate in the research Occurrence of possible clinical complications such as asthma Alcoholics

Design outcomes

Primary

MeasureTime frame
The score of severity of urticaria according to Urticaria Severity Score table. Timepoint: Measuring the intensity of urticaria on days 0-14-30 of the intervention. Method of measurement: UAS7 (urticaria activity score 7) questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before and after the intervention (end of the first month). Method of measurement: The quality of life questionnaire score of patients with chronic urticaria (Persian version).;Serological tests including IgE, eosinophil, C-reactive protein, ESR, interleukin (IL)-4, IL-63. Timepoint: Before and after the intervention (end of the first month). Method of measurement: laboratory.;Changing the need to take urticaria drugs. Timepoint: Before and after the intervention (end of the first month). Method of measurement: data collection form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Yousefi

Mashhad University of Medical Sciences

yousefim@mums.ac.ir+98 51 3884 8931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026